Hasan Jafri is Chief Medical Officer at Aridis Pharmaceuticals, Inc. (ARDS). They have made 1 open-market trade across 1 company since 2021, most recently 2023-06-05.
CIK 0001815352
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $21K since 2021, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ARDS | 15,100 | $5K |
Shares reported on the most recent Form 4, priced at the 2023-06-15 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ARDS | BUY | 2021-09-03 | 2021-09-08 | $4.15 | $21K | -4.1% | -13.5% | -38.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.